July 29, 2020 Go or no go? Valuable drugs set for FDA decisions Upcoming US approval verdicts include inclisiran, valrox and risdiplam, but toxicity issues could scupper filgotinib.
October 31, 2019 Go or no go? Agile and Lipocine hope to make it third time lucky Smaller projects dominate the list, but this doesn’t make them any less important for November’s hopefuls.
